Dimetacrine

ADVERTISEMENT

Identification

Molecular formula
C19H23NO2
CAS Number
4750-81-2
IUPAC Name
11-[3-(dimethylamino)propyl]-6H-benzo[c][1]benzoxepin-11-ol
Molecular Weight
293.39g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.1870g/cm3
Synonyms
Doxepinol
Interesting facts

Interesting Facts About 11-[3-(dimethylamino)propyl]-6H-benzo[c][1]benzoxepin-11-ol

This fascinating compound has garnered interest in the field of medicinal chemistry due to its unique structural properties and potential applications. Here are some key points that highlight its significance:

  • Structural Complexity: The compound features a complex architecture that includes a benzoxepine moiety. This structure provides unique interactions within biological systems, making it an intriguing subject for research.
  • Dimethylamino Functionality: The presence of a dimethylamino group enhances its pharmacological profiles. It can influence the compound's interaction with neurotransmitter systems, which is particularly important in drug design.
  • Research Potential: Compounds like this one are often evaluated for their potential in treating various neurological disorders. Its ability to modulate neurotransmitter activity could lead to new therapeutic strategies.
  • Application in Drug Development: The intricate design of such molecules makes them ideal candidates for novel drug development, particularly in fields like psychiatry and neurology.
  • Exploration in Pharmacology: Ongoing studies seek to understand how modifications in this compound's structure impact its efficacy, selectivity, and side effect profile, shaping future synthetic endeavors.

In essence, the study of 11-[3-(dimethylamino)propyl]-6H-benzo[c][1]benzoxepin-11-ol not only underscores the beauty of chemical design but also represents the ongoing quest for novel therapeutic agents in modern medicine. As one researcher eloquently put it, "The more we explore these complex molecules, the closer we get to unlocking new pathways for healing."

ADVERTISEMENT